Target intelligence / Profile preview

Elongin C pseudogene 28 (ELOCP28)

Target: ELOCP28
Molecular classification: Other (Pseudogene)

Overview

Elongin C pseudogene 28 (ELOCP28) is a non-protein-coding genomic region classified as a pseudogene for elongin C. It is also known as TCEB1P28. Unlike active protein-coding genes, pseudogenes typically lack biologically active transcripts or proteins and do not serve as therapeutic, enzymatic, or receptor targets. There is no evidence for involvement in disease or cellular pathways, nor for interaction with any drugs[1][7]. ELOCP28 is distinct from the functional elongin C gene (ELOC), which encodes a regulatory subunit of the SIII transcription elongation complex and is involved in RNA polymerase II activity and various ubiquitin ligase complexes[4][3]. ELOCP28 is only a pseudogene copy related to ELOC, with no known functional product.

Other names: TCEB1P28

Beyond the preview

Go deeper on Elongin C pseudogene 28 (ELOCP28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongin C pseudogene 28 (ELOCP28).

Explore the full profile